Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02411006 · ClinicalTrials.gov registry record · NA

Effect of Reminders on Adherence

A NA study of Hypertension and Diabetes, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
47,088
Enrollment target
1
Study location

NCT02411006 is a NA study of Hypertension and Diabetes that has completed, run by University of Pennsylvania. The registered enrollment target is 47,088 participants, above the 3,407-participant average among 470 other Hypertension trials with a reported enrollment target (1282% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02411006, a NA study of Hypertension and Diabetes, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
47,088 participants
Enrollment target
1
Study location

Study Summary

The investigators seek to increase medication adherence of subjects. The investigators will send mailings to customers of an insurance company, asking them to predict or commit to a certain level of behavior. The investigators will measure whether this increases medication adherence.

Conditions Studied

Interventions

  • BEHAVIORAL Prediction mailing
  • BEHAVIORAL Commitment mailing
  • BEHAVIORAL Reminder
  • BEHAVIORAL Anonymity
  • BEHAVIORAL Identification

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 47,088 participants
Start Date 2014-11
Est. Completion 2015-06
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT02411006

The ClinicalTrials.gov registry entry for NCT02411006 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47,088 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,407-participant average among 470 other Hypertension trials with a reported enrollment target (1282% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 5 interventions - of which Prediction mailing is the first listed.

NCT02411006 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02411006 about?

NCT02411006 is a clinical study titled "Effect of Reminders on Adherence". The investigators seek to increase medication adherence of subjects. The investigators will send mailings to customers of an insurance company, asking them to predict or commit to a certain level of behavior. The investigators will measure whether this increases medication adherence.

What is the current status of trial NCT02411006?

This trial is currently completed. It is a NA study. The enrollment target is 47,088 participants. The study started on 2014-11. Estimated completion is 2015-06.

What conditions does trial NCT02411006 study?

This clinical trial studies the following conditions: Hypertension, Diabetes.

What interventions are being tested in trial NCT02411006?

The interventions under investigation include: Prediction mailing (BEHAVIORAL), Commitment mailing (BEHAVIORAL), Reminder (BEHAVIORAL), Anonymity (BEHAVIORAL), Identification (BEHAVIORAL).

Who is sponsoring clinical trial NCT02411006?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02411006 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.